- Home
- LILAK vs CERT Comparison
LILAK vs CERT Comparison
Compare LILAK & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LILAK
- CERT
- Stock Information
- Founded
- LILAK 2017
- CERT 2008
- Country
- LILAK Bermuda
- CERT United States
- Employees
- LILAK N/A
- CERT N/A
- Industry
- LILAK Cable & Other Pay Television Services
- CERT Retail: Computer Software & Peripheral Equipment
- Sector
- LILAK Telecommunications
- CERT Technology
- Exchange
- LILAK Nasdaq
- CERT Nasdaq
- Market Cap
- LILAK 1.7B
- CERT 1.9B
- IPO Year
- LILAK N/A
- CERT 2020
- Fundamental
- Price
- LILAK $7.85
- CERT $11.55
- Analyst Decision
- LILAK Hold
- CERT Buy
- Analyst Count
- LILAK 2
- CERT 8
- Target Price
- LILAK $7.85
- CERT $15.57
- AVG Volume (30 Days)
- LILAK 686.1K
- CERT 1.6M
- Earning Date
- LILAK 11-05-2025
- CERT 11-06-2025
- Dividend Yield
- LILAK N/A
- CERT N/A
- EPS Growth
- LILAK N/A
- CERT N/A
- EPS
- LILAK N/A
- CERT 0.05
- Revenue
- LILAK $4,409,700,000.00
- CERT $405,755,000.00
- Revenue This Year
- LILAK $1.35
- CERT $11.70
- Revenue Next Year
- LILAK N/A
- CERT $8.03
- P/E Ratio
- LILAK N/A
- CERT $237.24
- Revenue Growth
- LILAK N/A
- CERT 11.61
- 52 Week Low
- LILAK $4.23
- CERT $8.64
- 52 Week High
- LILAK $10.67
- CERT $15.69
- Technical
- Relative Strength Index (RSI)
- LILAK 43.03
- CERT 43.81
- Support Level
- LILAK $7.71
- CERT $11.31
- Resistance Level
- LILAK $8.79
- CERT $12.94
- Average True Range (ATR)
- LILAK 0.33
- CERT 0.52
- MACD
- LILAK -0.06
- CERT -0.14
- Stochastic Oscillator
- LILAK 21.59
- CERT 16.51
About LILAK Liberty Latin America Ltd. Class C
Liberty Latin America Ltd is a telecommunications company. It is a provider of video, broadband internet, fixed-line telephony, and mobile services to residential and business customers. The company's reportable segments include C&W Caribbean, Liberty Networks, C&W Panama, VTR, Liberty Puerto Rico and Liberty Costa Rica. The company generates the majority of its revenue from C&W Caribbean, and Liberty Puerto Rico segments.
About CERT Certara Inc.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region.